Netherlands· NL-a87d52ab281d
Espikur 50 mg tabletten
A 13c-urea product containing ureum c13, registered in Netherlands by Laboratoires Mayoly Spindler. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
13c-urea is registered in 8 of 19 countries.
Countries holding a registration under ATC V04CX05 (13c-urea), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
13c-urea · ATC V04CX05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- UREUM C13
- Manufacturer
- Laboratoires Mayoly Spindler
- Country
- Netherlands (NL)
- ATC code
- V04CX05
- ATC class
- 13C-urea
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id123093
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
59 interactions on record for 13c-urea.
Graded by severity as the source publishes them — 58 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
13c-urea · interactions on record
59 records
- 58 moderate
- 1 minor
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Liquid paraffinA06AA01moderate
- BisacodylA06AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V04CX05
13c-urea, as other registers publish it.
- GermanyDiabact UbtLaboratoires Mayoly Spindler
- FinlandDiabact UbtLaboratoires Mayoly Spindler
- BelgiumEspikur 50 mgLaboratoires Mayoly Spindler
- FinlandHelicobacter Test InfaiINFAI GmbH
- SwitzerlandHelicobacter Test Infai
- DenmarkHelicobacter Test INFAIINFAI GmbH
- NorwayHelicobacter Test INFAIINFAI GmbH (1)
- NorwayHelicobacter Test INFAIINFAI GmbH (1)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/885d3a3d-0395-421a-bf0d-a57c213e09ac GET /v1/drugs/885d3a3d-0395-421a-bf0d-a57c213e09ac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123093_smpc.pdf",
"strength": null,
"atc_label": "C-urea",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123093",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CITROENZUUR 0-WATER (E 330)",
"CROSCARMELLOSE NATRIUM (E 468)",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)"
],
"substances": [
"UREUM C13"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123093.pdf",
"authorised_at": "2019/08/05",
"procedure_number": "SE/H/1829/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "123093",
"additional_monitoring": "N"
}See everything about 13c-urea.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.